エクセリキシス (EXEL) 2025年第1四半期決算発表

from モンティの米国株決算まとめポッドキャスト · host Monty trader

【#決算レポート】がん治療薬開発のエクセリキシス社(NASDAQ: EXEL)の2025年Q1決算を図解化📊 ✅ 総収益：$555.4百万（前年比+30.6%） ✅ 主力製品CABOMETYX®が好調（$513.3百万） ✅ 通期予測を$100百万上方修正！ ✅ 神経内分泌腫瘍(NET)治療薬として新たに承認取得詳細👇 https://tradermonty.github.io/trading-infographics/infographics/exelixis-q1-2025-earnings-release.html #バイオテック #製薬

What this episode covers

NOW PLAYING

0:00 6:38

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of モンティの米国株決算まとめポッドキャスト?

This episode is 6 minutes long.

When was this モンティの米国株決算まとめポッドキャスト episode published?

This episode was published on May 14, 2025.

What is this episode about?

Can I download this モンティの米国株決算まとめポッドキャスト episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!